News

Mark Two Newsletter Fall 2011 Issue

In this issue…

  • New Facility
  • Manufacturing Technology
  • Continuous Improvement and Employee Growth
  • Quality and Regulatory News

Mark Two Engineering is a contract engineering and manufacturing company specializing in rapid prototyping, high-precision machining and manufacturing. Mark Two Engineering is your single source supplier, and will fulfill all engineering and manufacturing requests from the prototype stage through high-volume production, assembly and packaging.


our new home Mark Two Newsletter Fall 2011 Issue

New Facility

A few miles north of our current facility will be the new location for Mark Two Engineering. The new facility will be ready for occupancy in 2012 and will accomodate product development, manufacturing and quality assurance. Lean Manufacturing facility layouts and new process improvements will maximize value to our customers through continued quality, efficient, cost effective manufacturing.



10 Mark Two Newsletter Fall 2011 Issue Manufacturing Technology

Mark Two Engineering recently purchased another five- axis machining center to add additional capacity for the machining of complex orthopedic component shapes. The benefits of five-axis machining is the machines ability to machine complex shapes in a single setup. This reduces setup times and increases production rates.





11 Mark Two Newsletter Fall 2011 Issue

Continuous Improvement and Employee Growth

We have recently launched an employee training program that will enable our employees to improve their technical knowledge and skill levels. We are fortunate to have a talented group of employees, and want to ensure that we provide a technical career ladder for them. Our training programs will be conducted by our engineers and subject matter experts to ensure that we have a continuous pipeline of talent to meet the future needs of our customers.



Quality and Regulatory News

The FDA commissioner (October 5, 2011) outlined steps to stimulate biomedical innovation, and to improve the health of Americans. The FDA blueprint focuses on implementing the following major actions:

  • Rebuilding FDA’s small business outreach services.
  • Building the infrastructure to drive and support personalized medicine.
  • Creating a rapid drug development pathway for important targeted therapies.
  • Harnessing the potential of data mining and information sharing while protecting patient privacy .
  • Improving consistency and clarity in the medical device review process .
  • Training the next generation of innovators.
  • Streamlining and reforming FDA regulations.